DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/3tp4c7/global_eyewear) has announced the addition of the “Global Eyewear Market Report: 2015 Edition” report to their offering. The global eyewear market consists…
Personalized Medicine: The Challenges Ahead
(MedPage Today) — Panel examines issues that could make or break “Precision Medicine” rollout
Uncategorized
Follow-up care system may educate patients, increase satisfaction
NEW YORK — Using MDbackline for automating contact with patients before and after office visits can save time, educate patients and help collect industry data, according to a speaker here. John A. Hovanesian, MD, FACS , presented the physician-patient process and the advantages of MDbackline, a patented, cloud-based follow-up care system, at OSN New York 2015.
Doc Groups Generally Positive on House Budget Deal
(MedPage Today) — Physicians will still get 0.5% Medicare pay raise
Shire to Resubmit Dry-Eye Disease Drug to FDA With New Study Data
Shire said its dry-eye disease drug lifitegrast significantly improved patient symptoms in a new study, supporting a re-submission of the medicine to U.S. regulators early next year. Reuters Health Information
Uncategorized
Ocular Therapeutix™ to Participate in Three Conferences in November 2015
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in three upcoming conferences in November including: Citi 2015 Global Healthcare 1×1 ConferenceWednesday, November 4, 2015The New York Palace Hotel, New York, NY Ophthalmology Innovation